V023-4171 Screening compound: 2-tert-butyl-4-(3-methylphenyl)-6-{4-[2-(morpholin-4-yl)ethyl]piperazin-1-yl}-2H-pyrazolo[3,4-d]pyrimidin-3-amine

V023-4171 Screening compound: 2-tert-butyl-4-(3-methylphenyl)-6-{4-[2-(morpholin-4-yl)ethyl]piperazin-1-yl}-2H-pyrazolo[3,4-d]pyrimidin-3-amine
V023-4171 Screening compound: 2-tert-butyl-4-(3-methylphenyl)-6-{4-[2-(morpholin-4-yl)ethyl]piperazin-1-yl}-2H-pyrazolo[3,4-d]pyrimidin-3-amine alternative view

Chemical Structure Depiction of ChemDiv screening compound V023-4171
2-tert-butyl-4-(3-methylphenyl)-6-{4-[2-(morpholin-4-yl)ethyl]piperazin-1-yl}-2H-pyrazolo[3,4-d]pyrimidin-3-amine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V023-4171

Molecular Formula

C26H38N8O (C26 H38 N8 O)

Compound Name

2-tert-butyl-4-(3-methylphenyl)-6-{4-[2-(morpholin-4-yl)ethyl]piperazin-1-yl}-2H-pyrazolo[3,4-d]pyrimidin-3-amine

IUPAC name

2-tert-butyl-4-(3-methylphenyl)-6-{4-[2-(morpholin-4-yl)ethyl]piperazin-1-yl}-2H-pyrazolo[34-d]pyrimidin-3-amine

SMILES

CC(C)(C)n(c(N)c12)nc2nc(N2CCN(CCN3CCOCC3)CC2)nc1-c1cc(C)ccc1

InChI

InChI=1S/C26H38N8O/c1-19-6-5-7-20(18-19)22-21-23(27)34(26(2,3)4)30-24(21)29-25(28-22)33-12-10-31(11-13-33)8-9-32-14-16-35-17-15-32/h5-7,18H,8-17,27H2,1-4H3

InChI Key

SCOMFGOASSQASK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14249674

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

478.64

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.102

Distribution Coefficient, logD

3.037

Water Solubility, LogSw

-3.14

Polar Surface Area

72.198

Acid Dissociation Constant (pKa)

20.43

Base Dissociation Constant (pKb)

6.61

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

57.70

V023-4171 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V023-4171 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V023-4171?
Check Price and Availability of V023-4171, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V023-4171 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V023-4171
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V023-4171
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V023-4171 available by request